Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

hyoscyamine-methenamine

hyoscyamine-methenamine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Urisedamine, L-hysocyamine-methenamine TABLET, ORAL 0.15 mg-500 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

hyoscyamine-methenamine (Urisedamine)

  • TWO 0.15 mg-500 mg tablets (Total: 0.3 mg-1,000 mg) QID

methenamine mandelate (Mandelamine)                                                                    

  • TWO 500 mg tablets (Total: 1,000 mg) QID
Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved